The world’s biggest dairy co-operative will review its stake in Chinese formula milk company Beingmate after unveiling the first ever annual loss in its 17-year history.
Aspen Pharmacare Holdings Limited, a global pharmaceutical company based in South Africa, has announced today, in conjunction with the announcement of its annual results for the year ended June 30, 2018, that it has concluded an agreement to divest of...
Health and Happiness (H&H) achieved a revenue of RMB4573.6m (about US$669m) in the first half of 2018, which is 28.8% higher than the same period last year.
A lack of specific EU rules for infant formula and sports nutrition products could lead to a lower level of protection for consumers increasing their risk of malnourishment according to a European industry association.
FrieslandCampina DOMO’s new Human Milk Oligosaccharide (HMO) ingredient, 2’-fucosyllactose (2’-FL), has been officially certified to be used in infant formula in both European and US markets.
UK firm Kendal Nutricare has signed a US$118m five-year contract deal with import / export company Orient International Holding Shanghai Foreign Trading Co. to distribute its organic infant formula in China.
The producer, supermarkets, public authorities and laboratories have ‘failed the consumer’ in the Lactalis infant formula contamination scandal, according to foodwatch.
The fallout from a report questioning Nestlé’s approach to marketing infant formula continued as the report’s authors urged the firm to provide “meaningful” answers in their response to the allegations.
Accusations levelled at Nestlé claim the Swiss corporate giants mislead consumers with nutritional claims about its infant formula products, flouting ethical marketing codes in the process.
China’s new infant formula laws have finally come into force, 18 months after the proposals were unveiled sparking regulatory uncertainty, market volatility and a frantic dash to meet the more stringent regulatory requirements.
Four leading manufacturers of milk formulas have been accused of boosting profits by exploiting parents’ desire to give the best possible nutrition to their offspring.
The Punjab Food Authority (PFA) has issued a blanket ban on marketing and free sampling of infant formula in hospitals in Pakistan, following a meeting with Formula Milk Association office bearers on 26 September.
Digestive health and protein content are the top two priorities for infant formula manufacturers in APAC, leading to a surge in interest in prebiotics, probiotics and oligosaccharides.
Changes to the gut’s microbial diversity, as a result of a modern lifestyle, may be responsible for a rise in chronic diseases, such as asthma, obesity and inflammatory bowel disease, an expert suggests.
Reports that some infant formula products on sale in Australia and New Zealand contain potentially 'dangerous' nanoscale particles have been dismissed by regulators and scientists — with one branding it blatant 'scaremongering'.
Supplementation with a synbiotic combination could help normalise the microbiota of infants born by Caesarean, according to new research heralded as a ‘big step’.
Infant nutrition is in the business of ‘selling sleep’ according to the CEO of Food for Health Ireland in a panel discussion at the trade event Vitafoods.
Altering the droplet size and coating of fats used in infant milk could modify postprandial responses in men, according to new research deemed 'very important' by the authors.
Last month’s decision by the Chinese food regulator to implement stricter food safety rules governing formulation and marketing is likely to wipe out a fair number of small- and medium-sized infant formula businesses in a highly competitive market.
Aptamil, one of Danone’s infant formula brands sold in 45 countries, has been launched in India, with the company saying it plans to produce local supply at the company’s Lalru, Punjab facility.
Replacing CEO Laura McBain hasn’t seen the end of financial turmoil at Australian infant formula manufacturer Bellamy’s with shares continuing to slide amid gloomy forecasts from analysts.
Food and nutrition firms in APAC have to contend with a diverse and at times contradictory regulatory landscape across the region, with rules and laws being amended or introduced all the time. And 2016 was no exception.
Danone’s Milupa Nutricia has signed a deal with online retailer windeln.de to better distribute its Aptamil infant formula brand in China as it seeks to thwart the booming grey market.
Restricting mothers’ access to information about infant formula may have negative public health consequences, trade group Specialised Nutrition Europe (SNE) has said following a draft Romanian law banning the marketing of formula for under-2s.
An experimental formula fortified with a specific human milk oligosaccharide may modify the immune profile of infants similar to that observed in breastfeeding, says a new study from Abbott Nutrition.
Romania wants to ban the promotion of infant formula products for children up to the age of two years, but it remains to be seen whether this draft law will make it past EU scrutiny.
With the World Health Organisation (WHO) and respected British journal The Lancet recently calling for tighter regulation and enforcement to better control infant formulae marketing, Aurélie Perrichet executive director of sector group Specialised Nutrition...
A new report says countries’ efforts to support breastfeeding in the face of infant formula promotion aren’t effective enough, but industry says it is playing by complicated and changing rules.
Respected British medical journal The Lancet says global infant formula marketing regulations need tightening – including a complete ban on social media channels.
Attendees of the UK Royal College of Paediatrics and Child Health’s (RCPCH) annual meeting have voted to cut its financial ties with infant formula companies.
New product development (NPD) is essential to address the nutritional needs of a child during its first 1000 days if health systems are to avoid the crippling cost of treating non-communicable diseases, warns a leading consultant and speaker at Food Vision...
An EFSA-approved health claim relating to infant immune system function will spread consumer confidence, a nutritionist says, although a pro-breast milk feeding group warns the claim could be abused.
Three US consumers have filed a class action lawsuit against Abbott Laboratories, claiming its Similac Advance Organic infant formula contains 26 ingredients not permitted in organic food.
Abbott Laboratories is launching a non-GMO version of its popular Similac Advance infant formula in the US - a decision its denies was fuelled by pressure from campaigners.
The “easy money has been made” for Chinese and international infant formula companies as they prepare for the rush for powdered baby food to tail off over the next five years after a decade’s stratospheric growth.
The New Zealand Commerce Commission has granted infant formula industry association, the Infant Nutrition Council (INC), the power to restrict the marketing practices of its members.
Police investigating a threat to contaminate New Zealand infant formula with sodium monofluoroacetate (1080) are testing tins after a number of consumers complained of pinpricks in packaging lids.
The infant formula industry has a "responsibility to adhere" to the principles of the WHO Code, manufacturer representatives from all corners of the globe agree.
Infant formula makers are focused on immunity and cognitive health but should turn to essential vitamins and minerals where they could make easier progress with claims, says a consultant.
South African pharmaceutical giant Aspen has set its sights on China after agreeing to acquire a 50% stake in infant formula manufacturer, New Zealand New Milk (NZNM).
FrieslandCampina and China Huishan Dairy have entered into a joint venture to produce and sell infant formula in China under one of the Dutch dairy's existing brands.
Meiji infant formula sold in Taiwan will in future be exported from Japan as the company looks to capitalize on the "high quality" reputation held by Japanese goods.